Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of HIV reverse transcriptase

Inhibitors of HIV reverse transcriptase

US Patent 5308854 · Granted May 3, 1994

Estimated economic value: $21,078,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compounds and uses thereof2022
Therapeutic compounds and uses thereof2021
Pyrazolo[ 1,5a]pyrimidine derivatives as IRAK4 modulators2021
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof2021
Hindered disulfide drug conjugates2020
Therapeutic compounds and uses thereof2020
Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors2019
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors2018
Substituted quinolizine derivatives useful as HIV integrase inhibitors2018
4-pyridinonetriazine derivatives as HIV integrase inhibitors2017
Spirocyclic hetercycle compounds useful as HIV integrase inhibitors2017
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors2017